Thursday, February 16, 2012
potassium kalium hyperkalemia
SUMMARY AND COMMENT
Dual Therapy with Aliskiren plus ACE Inhibitor or ARB Is Linked to Hyperkalemia
February 9, 2012 | Paul S. Mueller, MD, MPH, FACP | General Medicine
Risk was about 50% higher with dual therapy than with monotherapy.
Reviewing: Harel Z et al. BMJ 2012 Jan 9; 344:e42
# posted by roodbont @ 8:56 AM 
